Cargando…

Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1–13)-NH(2)

[Image: see text] Nociceptin/orphanin FQ (N/OFQ) controls different biological functions via selective stimulation of the N/OFQ peptide (NOP) receptor. The pleiotropic actions of N/OFQ may limit the development of NOP ligands as innovative drugs in different therapeutic areas. The pharmacological co...

Descripción completa

Detalles Bibliográficos
Autores principales: Pacifico, Salvatore, Ferrari, Federica, Albanese, Valentina, Marzola, Erika, Neto, Joaquim Azevedo, Ruzza, Chiara, Calò, Girolamo, Preti, Delia, Guerrini, Remo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011926/
https://www.ncbi.nlm.nih.gov/pubmed/32901477
http://dx.doi.org/10.1021/acs.jmedchem.9b02057
_version_ 1783673289408774144
author Pacifico, Salvatore
Ferrari, Federica
Albanese, Valentina
Marzola, Erika
Neto, Joaquim Azevedo
Ruzza, Chiara
Calò, Girolamo
Preti, Delia
Guerrini, Remo
author_facet Pacifico, Salvatore
Ferrari, Federica
Albanese, Valentina
Marzola, Erika
Neto, Joaquim Azevedo
Ruzza, Chiara
Calò, Girolamo
Preti, Delia
Guerrini, Remo
author_sort Pacifico, Salvatore
collection PubMed
description [Image: see text] Nociceptin/orphanin FQ (N/OFQ) controls different biological functions via selective stimulation of the N/OFQ peptide (NOP) receptor. The pleiotropic actions of N/OFQ may limit the development of NOP ligands as innovative drugs in different therapeutic areas. The pharmacological concept of functional selectivity (aka biased agonism) might be useful for amplifying beneficial actions and/or counteracting side effects. Thus, molecules with large bias factors toward G protein or β arrestin are required for investigating the translational value of NOP biased modulation. Herein, the biased behavior of a heterogeneous library of NOP-targeting peptide derivatives was evaluated in vitro with the aim to provide possible insights into the structural determinants that govern the selective activation of G protein versus β-arrestin. Our results demonstrate that lipidation of N/OFQ(1–13)-NH(2) is a useful strategy for obtaining G protein biased agonists for the NOP receptor.
format Online
Article
Text
id pubmed-8011926
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-80119262021-04-02 Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1–13)-NH(2) Pacifico, Salvatore Ferrari, Federica Albanese, Valentina Marzola, Erika Neto, Joaquim Azevedo Ruzza, Chiara Calò, Girolamo Preti, Delia Guerrini, Remo J Med Chem [Image: see text] Nociceptin/orphanin FQ (N/OFQ) controls different biological functions via selective stimulation of the N/OFQ peptide (NOP) receptor. The pleiotropic actions of N/OFQ may limit the development of NOP ligands as innovative drugs in different therapeutic areas. The pharmacological concept of functional selectivity (aka biased agonism) might be useful for amplifying beneficial actions and/or counteracting side effects. Thus, molecules with large bias factors toward G protein or β arrestin are required for investigating the translational value of NOP biased modulation. Herein, the biased behavior of a heterogeneous library of NOP-targeting peptide derivatives was evaluated in vitro with the aim to provide possible insights into the structural determinants that govern the selective activation of G protein versus β-arrestin. Our results demonstrate that lipidation of N/OFQ(1–13)-NH(2) is a useful strategy for obtaining G protein biased agonists for the NOP receptor. American Chemical Society 2020-09-09 2020-10-08 /pmc/articles/PMC8011926/ /pubmed/32901477 http://dx.doi.org/10.1021/acs.jmedchem.9b02057 Text en Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Pacifico, Salvatore
Ferrari, Federica
Albanese, Valentina
Marzola, Erika
Neto, Joaquim Azevedo
Ruzza, Chiara
Calò, Girolamo
Preti, Delia
Guerrini, Remo
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1–13)-NH(2)
title Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1–13)-NH(2)
title_full Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1–13)-NH(2)
title_fullStr Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1–13)-NH(2)
title_full_unstemmed Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1–13)-NH(2)
title_short Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1–13)-NH(2)
title_sort biased agonism at nociceptin/orphanin fq receptors: a structure activity study on n/ofq(1–13)-nh(2)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011926/
https://www.ncbi.nlm.nih.gov/pubmed/32901477
http://dx.doi.org/10.1021/acs.jmedchem.9b02057
work_keys_str_mv AT pacificosalvatore biasedagonismatnociceptinorphaninfqreceptorsastructureactivitystudyonnofq113nh2
AT ferrarifederica biasedagonismatnociceptinorphaninfqreceptorsastructureactivitystudyonnofq113nh2
AT albanesevalentina biasedagonismatnociceptinorphaninfqreceptorsastructureactivitystudyonnofq113nh2
AT marzolaerika biasedagonismatnociceptinorphaninfqreceptorsastructureactivitystudyonnofq113nh2
AT netojoaquimazevedo biasedagonismatnociceptinorphaninfqreceptorsastructureactivitystudyonnofq113nh2
AT ruzzachiara biasedagonismatnociceptinorphaninfqreceptorsastructureactivitystudyonnofq113nh2
AT calogirolamo biasedagonismatnociceptinorphaninfqreceptorsastructureactivitystudyonnofq113nh2
AT pretidelia biasedagonismatnociceptinorphaninfqreceptorsastructureactivitystudyonnofq113nh2
AT guerriniremo biasedagonismatnociceptinorphaninfqreceptorsastructureactivitystudyonnofq113nh2